Trial · NCT00511706
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Injection Free Interval | Dexamethasone and Ranibizumab | 34 | Inter-Quartile Range 28 to 85 | Days | |
| Injection Free Interval | Sham and Ranibizumab | 29 | Inter-Quartile Range 28 to 56 | Days | |
| Change From Baseline in the Best Corrected Visual Acuity (BCVA) at Week 25 | Dexamethasone and Ranibizumab | Baseline | 55.5 | Standard Deviation 15.27 | Letters |
| Change From Baseline in the Best Corrected Visual Acuity (BCVA) at Week 25 | Sham and Ranibizumab | Baseline | 58.1 | Standard Deviation 12.64 | Letters |
| Change From Baseline in the Best Corrected Visual Acuity (BCVA) at Week 25 | Dexamethasone and Ranibizumab | Change from baseline at week 25 | 2.0 | Standard Deviation 8.61 | Letters |
| Change From Baseline in the Best Corrected Visual Acuity (BCVA) at Week 25 | Sham and Ranibizumab | Change from baseline at week 25 | 2.4 | Standard Deviation 9.14 | Letters |
| Change From Baseline in the Mean Central Retinal Subfield Thickness at Week 25 as Assessed by Optical Coherence Tomography (OCT) in the Study Eye | Dexamethasone and Ranibizumab | Baseline | 260.28 | Standard Deviation 123.625 | Microns |
| Change From Baseline in the Mean Central Retinal Subfield Thickness at Week 25 as Assessed by Optical Coherence Tomography (OCT) in the Study Eye | Sham and Ranibizumab | Baseline | 272.45 | Standard Deviation 130.829 | Microns |
| Change From Baseline in the Mean Central Retinal Subfield Thickness at Week 25 as Assessed by Optical Coherence Tomography (OCT) in the Study Eye | Dexamethasone and Ranibizumab | Change from baseline at week 25 (n=105, 111) | -7.12 | Standard Deviation 77.898 | Microns |
| Change From Baseline in the Mean Central Retinal Subfield Thickness at Week 25 as Assessed by Optical Coherence Tomography (OCT) in the Study Eye | Sham and Ranibizumab | Change from baseline at week 25 (n=105, 111) | -13.00 | Standard Deviation 97.651 | Microns |
| Change From Screening in the Area of Leakage From Choroidal Neovascularization (CNV) at Week 25 as Assessed by Fluorescein Angiography in the Study Eye | Dexamethasone and Ranibizumab | Screening | 8.44 | Standard Deviation 6.863 | Millimeters square (MM^2) |
| Change From Screening in the Area of Leakage From Choroidal Neovascularization (CNV) at Week 25 as Assessed by Fluorescein Angiography in the Study Eye | Sham and Ranibizumab | Screening | 8.12 | Standard Deviation 6.359 | Millimeters square (MM^2) |
| Change From Screening in the Area of Leakage From Choroidal Neovascularization (CNV) at Week 25 as Assessed by Fluorescein Angiography in the Study Eye | Dexamethasone and Ranibizumab | Change from Screening at Week 25 (n= 95,99) | -2.32 | Standard Deviation 4.927 | Millimeters square (MM^2) |
| Change From Screening in the Area of Leakage From Choroidal Neovascularization (CNV) at Week 25 as Assessed by Fluorescein Angiography in the Study Eye | Sham and Ranibizumab | Change from Screening at Week 25 (n= 95,99) | -1.73 | Standard Deviation 5.465 | Millimeters square (MM^2) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00511706/results